Tophaceous gout.

Neupane, Durga; Lageju, Nimesh; Jaiswal, Lokesh Shekher; Pandit, Narendra; Mahat, Asim; Ghimire, Saransh; Pokhrel, Upendra; Koirala, Sefali

Tophaceous gout.

Neupane, Durga; Lageju, Nimesh; Jaiswal, Lokesh Shekher; Pandit, Narendra; Mahat, Asim; Ghimire, Saransh; Pokhrel, Upendra; Koirala, Sefali.

Afiliação

Neupane D; B.P. Koirala Institute of Health Sciences Dharan Nepal.
Lageju N; B.P. Koirala Institute of Health Sciences Dharan Nepal.
Jaiswal LS; Department of Surgery (Division of CTVS) B.P. Koirala Institute of Health Sciences Dharan Nepal.
Pandit N; Department of Surgical Gastroenterology Birat Medical College Teaching Hospital (BMCTH) Biratnagar Nepal.
Mahat A; B.P. Koirala Institute of Health Sciences Dharan Nepal.
Ghimire S; Kathmandu Medical College and Teaching Hospital Kathmandu Nepal.
Pokhrel U; Patan Academy of Health Sciences Lalitpur Nepal.
Koirala S; College of Dental Surgery, B.P. Koirala Institute of Health Sciences Dharan Nepal.

Clin Case Rep ; 12(6): e9033, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38868124

ABSTRACT

ABSTRACT

Hyperuricemic patients (≥7.8 mg/dL) can develop polyarticular tophaceous gout from intermittent arthritis if untreated. Acute flares and tophi development can be avoided by lowering blood urate levels with xanthine oxidase inhibitors.

Palavras-chave

allopurinol; gout; hyperuricemia; monosodium urate; tophi

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google